MustGrow Outlines Upcoming Investment Conferences
SASKATOON, Saskatchewan, Canada, Apr. 15, 2021 – MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) (the “Company”, “MustGrow”) is pleased to announce its upcoming investor awareness initiatives. MustGrow continues to actively engage its key stakeholders – potential industry partners, shareholders and prospective investors – by increasing awareness of its natural mustard plant-based biopesticide technologies.
SnowCap Ventures – The Future of Food 2.0 Virtual Investor Conference
Thursday, April 15th at 1:40pm ET
CSE Earth Day Public Company Showcase – Virtual Investor Presentation
Thursday, April 22nd at 4:15pm ET
Benzinga CleanTech Small Cap Conference – Virtual Investor Conference
Thursday, April 22nd
Positive Soil Health and Environmental Impact
MustGrow’s safe and effective natural, organic biofumigant, biopesticide and bioherbicide are plant-based – harnessing the mustard seed’s natural defense mechanism to control diseases, insect pests and weeds.
The dangers associated with synthetic chemical overuse is pushing farmers, consumers and regulators to seek naturally-sourced biological products, which are known for safe, environmentally-sustainable and consumer-friendly profile characteristics. For instance, MustGrow recently announced the active ingredient in its mustard-based preplant soil biofumigant technology (AITC) has a positive soil health and environmental impact:
- Application of AITC as a biofumigant returns organic plant material to the soil;
- AITC dissipates in the soil quickly, avoiding long-term toxicity to beneficial micro-organisms;
- The impact of AITC on the environment is positive with very low water solubility, which could potentially limit runoff into the watershed; and
- Therefore, AITC promotes a healthy microbiome for the soil and is ecologically positive for the environment.
MustGrow is a publicly traded (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) agriculture biotech company focused on providing natural science-based biological solutions for high value crops, including fruits & vegetables and other industries. MustGrow has designed and owns a U.S. EPA-approved natural solution that uses the mustard seed’s natural defence mechanism to protect plants from diseases and insect pests. Over 110 independent tests have been completed, validating MustGrow’s safe and effective signature products. The product, in granule format, is EPA-approved across all key U.S. states and by Health Canada’s PMRA (Pest Management Regulatory Agency) as a biopesticide for high value crops such as in fruit & vegetables. MustGrow has now concentrated a mustard extract biopesticide in liquid format, TerraMG, and with regulatory approval, could be applied through standard drip or spray equipment, improving functionality and performance features. In addition, the Company’s mustard-derived extract technologies could have other applications in several different industries from preplant soil treatment, to weed control, to postharvest disease control and food preservation.
The Company has approximately 42.8 million basic common shares issued and outstanding and 50.6 million shares fully diluted. For further details please visit www.mustgrow.ca.
ON BEHALF OF THE BOARD
Director & CEO
Certain statements included in this press release constitute “forward-looking statements” which involve known and unknown risks, uncertainties and other factors that may affect the results, performance or achievements of MustGrow.
Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects”, “is expected”, “budget”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might”, “occur” or “be achieved”.
Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of MustGrow to differ materially from those discussed in such forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, MustGrow.
These risks are described in more detail in MustGrow’s Prospectus and other continuous disclosure documents filed by MustGrow with the applicable securities regulatory authorities and available at www.sedar.com. Readers are referred to such documents for more detailed information about MustGrow, which is subject to the qualifications, assumptions and notes set forth therein.
This release does not constitute an offer for sale of, nor a solicitation for offers to buy, any securities in the United States.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
© 2021 MustGrow Biologics Corp. All rights reserved.